Dr. Patrick Ramirez, MD

Dr. Ramirez practices at Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas.

Dr. Ramirez's NPI, 1013445097, was assigned on June 2, 2017. Dr. Ramirez graduated from The University of New Mexico School of Medicine in 2017. Dr. Ramirez holds Texas license S5746.

Dr. Ramirez's primary practice is Baylor Scott & White Continuing Care Hospital - Temple, at 2401 South 31st St, Temple, TX 76504 in Bell County. The practice phone is (254) 771-8200.

Dr. Ramirez's primary practice is Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas. Dr. Ramirez is also affiliated with Hendrick Medical Center. The medical group on file is Hendrick Provider Network. Dmand AI also links Dr. Ramirez to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramirez practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ramirez's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Ramirez is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Ramirez is licensed in Texas.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, irritable bowel syndrome (IBS) and peptic ulcer among the conditions Dr. Ramirez treats.

CMS data shows 162 Medicare services from Dr. Ramirez across 7 procedure codes in 2024, for 107 Medicare patients. Medicare paid $16,245 for them.

CMS counts 107 Medicare patients who saw Dr. Ramirez in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ramirez's median patient age at 72, with 56% women.

In 2024, Dr. Ramirez wrote 91 Medicare Part D claims for 38 patients. 78% of them were for generic drugs. CMS names the drug for 35 of them, across 2 drugs with 11 or more claims each, at $3,892 in total drug cost. In 2023, CMS named 27 claims across 2 drugs.

Dr. Ramirez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 222 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Ramirez, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Ramirez in 2019. Dr. Ramirez's most frequent co-authors are Raymond G. Duggan, DO, Alisha Marie Hinds, DO and Jonathan Charles Ramirez, MD.

CMS Open Payments shows 24 general payments to Dr. Ramirez from 12 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $233.

Dr. Ramirez graduated from The University of New Mexico School of Medicine in 2017.

Dr. Ramirez is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.